secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2026-07-15T10:01:33+00:00
Accession:  0001156039-26-000058
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health Q2 2026 EPS beats; raises full-year adjusted EPS guidance to at least $27.00
--------------------------------------------------------------------------------

- Operating revenue $49.8B (+0.8% YoY); diluted EPS $6.71, adjusted diluted EPS $7.45 (includes ~$0.80 net below-the-line benefit).
- FY 2026 GAAP EPS guidance raised to at least $20.10; adjusted EPS guidance raised to at least $27.00.
- Operating cash flow guidance raised to at least $6.0B; Q2 operating cash flow $1.9B.
- Health Benefits segment operating margin fell to 2.1% from 3.8% YoY; medical membership ~44.9M, down 469K sequentially.
- Quarterly dividend declared $1.72 per share, payable Sept 25, 2026 to holders of record Sept 10, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000115603926000058/0001156039-26-000058-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000115603926000058/elv-20260715.htm
  HTML page:      https://secwatch.observer/filing/0001156039-26-000058

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer